General
Preferred name
VISMODEGIB
Synonyms
GDC0449 ()
GDC-0449 ()
Erivedge ()
RG 3616 ()
GDC-0449 (Vismodegib) ()
GDC 0449 ()
Vismodegib, free base ()
V-4050 ()
2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide ()
Vismodegib (GDC-0449) ()
NSC-755986 ()
NSC-747691 ()
P&D ID
PD004109
CAS
879085-55-9
Tags
natural product
drug
available
Approved by
EMA
FDA
First approval
2012
Drug Status
investigational
approved
Drug indication
Basal cell carcinoma
Primitive neuroectodermal tumour medulloblastoma
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Vismodegib inhibits smoothened homolog (SMO), a constituent of the Hedgehog signalling pathway which is essential for proper embryonic development. This pathway is also involved in the maintenance and regeneration of adult tissues by regulating adult stem cells and has been implicated in the development of some cancers. (GtoPdb)
Cell lines
118
Organisms
0
Compound Sets
26
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Approved Oncology Drugs
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Welcome Trust Cancer Drugs
ZINC Tool Compounds
External IDs
36
Properties
(calculated by RDKit )
Molecular Weight
420.01
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
3
cLogP
4.71
TPSA
76.13
Fraction CSP3
0.05
Chiral centers
0.0
Largest ring
6.0
QED
0.66
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
SMO
Hedgehog
ABCG2
Hedgehog inhibitor
Pathway
GPCR/G protein
Stem Cells
Membrane Transporter/Ion Channel
Autophagy
Stem Cell/Wnt
MOA
Hedgehog/Smoothened
hedgehog pathway inhibitor, smoothened receptor antagonist
Indication
basal cell carcinoma (BCC)
Source data